Last reviewed · How we verify
Ecthyma gangrenosum
Approved treatments
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ecthyma gangrenosum patent landscape — cliff calendar, originator estates, attackable patents
- Ecthyma gangrenosum treatment landscape brief
- Ecthyma gangrenosum treatment updates RSS
Frequently asked questions about Ecthyma gangrenosum
What drugs treat Ecthyma gangrenosum?
Tracked treatments include Fortaz, Ceftazidim.
What is the treatment for Ecthyma gangrenosum?
Standard treatment for Ecthyma gangrenosum includes Fortaz, Ceftazidim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ecthyma gangrenosum patent cliff · Ecthyma gangrenosum CI report
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Ceftazidim · Tel-Aviv Sourasky Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing